DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
The DrugRisk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com
Dallas, TX (PRWEB) January 30, 2013
The patient advocates at DrugRisk.com are alerting those taking the blood thinner Pradaxa of new information added to the site which shows the judge presiding over the ongoing internal bleeding lawsuits has ordered the drug maker to disclose information on prior fraud charges.
The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. “In many cases, patients follow litigation to learn more about a drug they´re taking and what questions to ask their doctor,” explains DrugRisk representative Ryan Mayer.
The resource center previously added a report from the Institute for Safe Medication Practices which ranked anticoagulants like Pradaxa among the highest risk outpatient drugs. The Institute also found that hemorrhage cases submitted to the FDA show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.*
Reports show that experts still disagree about the safety of Pradaxa and its bleeding risks. While there has been no official Pradaxa recall, the FDA recently issued an update that the drug carries the same risks as warfarin.** However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.***
DrugRisk has learned that, due to the number of patients filing a Pradaxa lawsuit, they are being consolidated in a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
Now, the resource center has learned that, Judge Herndon, who is overseeing the Pradaxa litigation, signed an order on January 19th denying attempts by Pradaxa maker Boehringer Ingelheim to protect information on prior lawsuits regarding false promotion, marketing or kickbacks for their drugs.****
Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.
For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*Instutute for Safe Medication Practices, 1/9/13; http://ismp.org/quarterwatch/pdfs/2012Q2.pdf
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-litigation/pradaxa-recalled/prweb10355992.htm